Navigation Links
Valeant Pharmaceuticals Announces Management Change
Date:9/13/2012

MONTREAL, Sept. 13, 2012 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced today that Rajiv De Silva, Valeant's President and Chief Operating Officer of Specialty Pharmaceuticals, will be leaving the Company to pursue other interests. Mr. De Silva will remain with the Company through the remainder of the year, when the integration planning efforts related to its announced acquisition of Medicis Pharmaceutical Corporation (NYSE: MRX) are expected to have been completed.  Mr. De Silva will be a core member of the team leading these integration planning efforts. In addition, we expect that a number of Medicis executives would accept positions with Valeant after the acquisition has been completed.

"The Board of Directors and I appreciate the significant contributions Rajiv has made these past few years since joining me on this journey to create a new pharmaceutical operating model," said J. Michael Pearson, chairman and chief executive officer.  "Under Rajiv's leadership, we have become a leader in the U.S. dermatology space and transformed our operations in Canada and Australia. And although his leadership will be missed, the company has created and developed a strong management team with Rajiv's assistance that I am confident will lead us successfully through this transition period and into the future."

"The last four years at Valeant has been an extraordinary experience," said Rajiv De Silva.  "It has been a privilege to work with Mike, other members of the management team, and the Board on this journey."

About Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range
'/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Valeant Pharmaceuticals To Present At UBS Annual Global Life Sciences Conference
2. Valeant Pharmaceuticals International, Inc. Agrees To Acquire Medicis Pharmaceutical Corporation For $44.00 Per Share In Cash
3. Valeant Pharmaceuticals To Announce 2012 Second Quarter Results On August 2, 2012
4. Valeant Pharmaceuticals To Host Investor Day
5. Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results
6. Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
7. Isis Pharmaceuticals Completes Redemption Of 2 5/8% Convertible Subordinated Notes Due 2027
8. Edison Pharmaceuticals Announces Positive Results of EPI-743 Phase 2A Leigh Syndrome Clinical Trial
9. Gerri Henwood Joins Actinium Pharmaceuticals as Chief Development Officer
10. EMA Grants Orphan Designation to Edison Pharmaceuticals for EPI-743 for Treatment of Leigh Syndrome
11. Epigenomics, Present and Future Applications for Pharmaceuticals and Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... Solta Medical, Inc. (NASDAQ: SLTM ), ... Dr. Edward W. Knowlton has resigned ... immediately.  Dr. Knowlton is the founder of Thermage, the predecessor ... since 1996. "On behalf of the entire Board ... like to thank Ed for his tireless dedication to our ...
(Date:5/24/2013)... -- An international roster of experts on malignant pleural mesothelioma ... Santa Monica, Calif. , to discuss their latest ... rare form of cancer that results from exposure to ... the chest. Hosted by UCLA and the ... International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma ...
(Date:5/24/2013)... , May 24, 2013  Heska Corporation (NASDAQ: HSKA, ... and specialty products, announced today that Dr. Robert ... and Jason Napolitano , executive vice president ... Marcum MicroCap Conference, which is being held May 30, 2013 ... Grand Hyatt Hotel. The Company,s presentation is ...
Breaking Medicine Technology:Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc. 2International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 2International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 3Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference 2
... helping pharmacies extend services to more patients, improve ... many rural health care and emergency facilities across ... technician to be remotely supervised in real time ... prepare prescriptions. (Logo: http://photos.prnewswire.com/prnh/20120301/DC62761LOGO ) ...
... BEIJING, May 17, 2012 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical ... or the "Company"), an emerging leader in the development, ... medical products, today announced that the Company will present ... be held at the Shanghai Purple Mountain Hotel in ...
Cached Medicine Technology:Rural Health-Systems Benefit From Remote Pharmacy Technician Supervision 2Rural Health-Systems Benefit From Remote Pharmacy Technician Supervision 3Dehaier Medical to Present at the CFA 2012 Cross-Continental Summit on Investment in Shanghai 2
(Date:5/24/2013)... measuring fractional flow reserve (FFR) using pressure wire ... pain leads to significant changes in the management ... from a study reported at EuroPCR 2013. , ... management strategy at coronary angiography for diagnosis of ... routine assessment of FFR in all the main ...
(Date:5/24/2013)... Beach Gardens, FL (PRWEB) May 24, 2013 ... surgeons jealous, Dr. Greg DeLange of the Estetica ... of the hosts of KOOL 105.5 FM’s popular morning show, ... the air about their experiences and their satisfaction with the ... Institute, a cutting-edge facility located in Palm Beach Gardens, very ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 Electric™ Energy Straws, ... fueling IndyCar Rookie Carlos Munoz and will be the lead ... 500 at the Indianapolis Motor Speedway. Munoz, who is part ... speed of 228.342 mph in race, qualifying to be named ... the first row in Sunday’s race. , While Munoz ...
(Date:5/24/2013)... OH (PRWEB) May 24, 2013 ... provider of barcode identification, tracking and data management ... acquired Triangle Biomedical Sciences Inc., (TBS) of Durham, ... instrumentation, reagents and consumables for the clinical and ... of General Data Healthcare, which provides specialty products ...
(Date:5/24/2013)... New research presented today shows that formation of new ... for its importance in learning and remembering - could ... of existing brain circuits. Drs. Paul Frankland and ... in Toronto, argue this reorganization could have the positive ... increasing capacity for new learning. These results were ...
Breaking Medicine News(10 mins):Health News:Diagnostic coronary angiography: Functional flow reserve changes decisions in 25 percent of cases 2Health News:Dr. Greg DeLange of the Estetica Institute Recently Performed Eye Surgery on Both Members of Popular Morning Radio Team 2Health News:Unistraw Electric™ Energy Straw Chevy Car Powers Indianapolis 500 Rookie Driver Carlos Munoz 2Health News:Unistraw Electric™ Energy Straw Chevy Car Powers Indianapolis 500 Rookie Driver Carlos Munoz 3Health News:General Data Acquires Triangle Biomedical Sciences 2Health News:General Data Acquires Triangle Biomedical Sciences 3Health News:New neuron formation could increase capacity for new learning, at the expense of old memories 2
... , ... products and services provider DHS Technologies LLC recently revealed its newest shelter system – ... ... Technologies LLC recently revealed its newest shelter system – the Reeves Mobile Vaccination System., ...
... ... income in the current economy, and who are looking to better their health, too, can ... enlisting interested business leaders nationwide., , ... (PRWEB) March 16, 2010 -- Independent businessman Brad Aspin and leading health and wellness ...
... Large amounts of frozen plasma are being used inappropriately, ... Medical Association Journal ) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj081933.pdf ... the clinical use of red blood cells and platelets ... of frozen plasma. "Two recent studies in Canada ...
... ... ... SAN RAFAEL, Calif. , March 15 The following was released today by the Marin Institute: , ... , , ...
... March 15 Spotlighting the importance of oral health care for expectant mothers, the California Dental Association (CDA) Foundation has released new guidelines designed to emphasize the safety of ... ... ... ...
... , March 15 The Board of Directors of Healthcare Trust of America, Inc. ("HTA"), ... June 2010 .  These distributions will be calculated based on the stockholders of record each day ... $10.00 . , ... ...
Cached Medicine News:Health News:DHS Technologies Unveils New Mobile Vaccination System 2Health News:Brad Aspin and Health and Wellness Company GBG Now Looking for Leaders Nationwide 2Health News:Advocates Rally Southland Assembly Health Committee Members to Pass AB 1694 2Health News:Advocates Rally Southland Assembly Health Committee Members to Pass AB 1694 3Health News:Advocates Rally Southland Assembly Health Committee Members to Pass AB 1694 4Health News:California Dental Association Foundation Releases New Oral Health Guidelines for Pregnant Women 2Health News:California Dental Association Foundation Releases New Oral Health Guidelines for Pregnant Women 3Health News:California Dental Association Foundation Releases New Oral Health Guidelines for Pregnant Women 4Health News:Healthcare Trust of America Board of Directors Declares Distributions 2Health News:Healthcare Trust of America Board of Directors Declares Distributions 3
Indications For Usage: ,Airway management during anesthesia or short-term surgical procedures....
Indications For Usage: , Airway management during surgical procedures. , Long-term ventilatory management. ...
Indications For Usage: , Nasal surgery. , Ophthalmic surgery. , Facial surgery. , T&A surgery. ...
Indications For Usage: ,Airway management during pediatric surgical procedures and intensive care....
Medicine Products: